Tigam, Narcita M.
HRN: 04-68-91 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/03/2022
CEFTRIAXONE 1G (VIAL)
06/03/2022
06/09/2022
IV
2g
OD
Presumptive TB; UTI
Waiting Final Action